Tillotts Pharma AG

Quick facts

Marketed products

• Mesalamin · Other

Phase 3 pipeline

• TP05 · Dermatology
  TP05 is a topical phosphodiesterase 4 (PD4) inhibitor that reduces inflammatory cytokine production in skin.

Phase 1 pipeline

• TP05 Coating A
• TP05 Coating B
• TP05 Coating D
• TP05 Coating E
• TP05 Coating H

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Tillotts Pharma AG portfolio CI brief
• Tillotts Pharma AG pipeline updates RSS